Calithera Biosciences Reports Second Quarter 2020 Financial Results and Recent Highlights

    NEXT STORY
    Equillium Announces Positive Interim Data with Itolizumab in Acute GVHD Study
    PREV STORY
    Chiasma Reports Second Quarter 2020 Results and Significant Progress on Launch Preparedness
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    BriaCell Completes Share Consolidation

    author_avatar
    NASDAQ Market News

    BioXcel Therapeutics Announces Primary and Secondary Endpoints Met in Two Pivotal Phase 3 Trials of BXCL501 for the Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorder

    author_avatar
    NASDAQ Market News

    Oncology Venture: Kallelse till extra bolagsstämma

    INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLINGNOTICE TO CONVENE EXTRAORDINARY GENERAL MEETINGKALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes ...

    author_avatar
    NASDAQ Market News